fashion -WSS

fashion

author：leisure time 2025-09-29 23:04:39 - browse：67773

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

LONDON — The booming obesity market is attracting another player, as pharma giant Roche said Monday it was acquiring Carmot Therapeutics and the company’s line of weight loss drug candidates for $2.7 billion upfront.

The deal for Carmot, which is based in Berkeley, Calif., includes additional milestone payments of up to $400 million. Carmot is privately held, though it had filed paperwork last month for an initial public offering.

As part of the deal, Roche is gaining three experimental obesity medicines from Carmot, which are in Phase 1 or Phase 2 testing, as well as preclinical programs. While two are injectable treatments, one is being developed as an oral drug. They all target GLP-1 hormone receptors, while two are also designed to work via receptors for another hormone called GIP.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Flagship Pioneering startup Sonata Therapeutics lays off 21

WSS

Secretariat’s lessons for human medicine

Microsoft's Peter Lee: Generative AI could help doctors be more human

A new approach to psychiatric drug development

Microsoft's Peter Lee: Generative AI could help doctors be more human

A new drug could help frostbite victims avoid its ravages

Hospitals are piloting generative AI tools as regulators play catch

explore

fashion

leisure time

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Why Talkspace is targeting Medicare, a tricky market

Cancer drug shortages should be causing more outrage

Why Talkspace is targeting Medicare, a tricky market

Psychedelics group wrestles with new pharma identity

State of the Union pitch: Bigger Medicare drug price negotiations

Cancer drug shortages should be causing more outrage

Biden's 'march

Hepatitis C has a cure — but many Americans still lack access to it

Why Talkspace is targeting Medicare, a tricky market

knowledge

For AI in health care standards, federal regulators join with industry group

$1 billion proposal to grow Boston, Massachusetts biotech

Congress may force more Covid

Streamlined flu vaccines recommended by FDA advisory panel

Reporting on presidential health from Reagan to Trump and Biden

The untold story of TV’s first prescription drug ad

hotspot

leisure time

leisure time

hotspot